Post Trial Access

We offer a cost effective alternative to an Open Label Extension

Post Trial Access

Inceptua provides pharmaceutical companies with a cost-effective solution to ensure the ongoing provision of treatment for clinical trial participants once the trial ends, and until a medication becomes commercially available.

 

Following the completion of a clinical trial, pharmaceutical companies usually have a responsibility to maintain the supply of an investigational medicines to patients until it becomes available in the commercial market. Moreover, in cases where a drug doesn’t succeed in its clinical trial or the pharmaceutical company decides to halt its development, there might still be commitments to supply the trial medication to patients who have experienced clinical benefits. This often leads to the pharmaceutical companies to keep the clinical trial sites open which carries an ongoing expense and allocation of internal resources.

 

Inceptua provides pharmaceutical companies with a cost effective option to bridge the treatment gap for trial patients until the medication is commercially available, or until the patients have completed their treatment.

Why Inceptua:

1. One single, trusted partner to continue the supply of medicines from your clinical trial to patients once the trial has come to an end and up to the point of commercial availability

 

2. Asset-specific Program Strategy – Successful programs (300+ programs) devised through deep Early Access and commercial pharma experience to develop Post Trial Supply strategies to synergize with your strategic decisions

 

3. Global Competence – Global coverage for your program in more than 120 markets worldwide, with deep experience in complex markets

 

4. Industry Thought-Leaders – Pioneering team in the Early Access world, having developed industry standard services means you receive industry-best guidance, adapting to external developments in real-time to ensure optimal program performance

Any questions?

Ask our experts

About

Mark has specialized in access programs for over 12 years and leads Medicines Access.
EXECUTIVE VICE PRESIDENT
MEDICINES ACCESS

Mark Corbett

About

With over 20 years of industry experience, Stuart leads the consulting arm of our Medicines Access team.
VICE PRESIDENT CONSULTING
MEDICINES ACCESS

Stuart Bell

About

With 20 years experience in the pharmaceutical industry, Ruth leads the implementation of our pre-approval access programs.
VICE PRESIDENT PROJECT MANAGEMENT
MEDICINES ACCESS

Ruth Rostron

About

Kelly has 25 experience in regulatory affairs and quality assurance, 10 of which specializing in Medicines Access regulations
SENIOR DIRECTOR
HEAD OF REGULATORY

Kelly Fearn

We are here to help
by providing vital advisory
and practical support for the
biopharmaceutical industry,
healthcare professionals, and
patient advocacy groups.

Early Access News and Insights

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.